Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

In Silico Identification of Novel Quinoline-3-carboxamide Derivatives Targeting Platelet-Derived Growth Factor Receptor

Author(s): Ganesh S. Mhaske*, Ashim K. Sen, Ashish Shah, Rahul H. Khiste, Ajit V. Dale and Dhanya B. Sen

Volume 18, Issue 2, 2022

Published on: 06 July, 2022

Page: [131 - 142] Pages: 12

DOI: 10.2174/1573394718666220421111546

Price: $65

Abstract

Background: Several computer-aided drug design (CADD) methods enable the design and development of novel chemical entities. Structure-based drug design (SBDD) and the knowledge of in silico methods enable the visualization of the binding process of ligands to targets and to predict the key binding pocket sites and affinity of ligands to their target macromolecules.

Objective: The present study was carried out to identify novel N-2-amino-N-phenyl quinoline-3- carboxamide (AQCMs) derivatives targeting Platelet-derived growth factor receptor (PDGFR) to cure cancer using in silico approach.

Materials and Methods: AQCMs were designed using ChemAxon Marvin Sketch 5.11.5 software. SwissADME and admetSAR online webserver were used to predict physicochemical properties as well as the toxicity of compounds. Ligand-receptor interactions between quinoline-3-carboxamide derivatives with the target receptor (PDB: 5GRN) were carried out using molecular docking technique by employing various software like AutoDock 1.1.2, MGL Tools 1.5.6, Discovery Studio Visualizer v 20.1.0.19295, Procheck, ProtParam tool, and PyMOL.

Results: In silico results reveal that all designed compounds had acceptable pharmacokinetic properties, were found to be orally bioavailable, and less harmful. Molecules from 36 to 39 showed better docking scores as compared to standard drugs sunitinib and tasquinimod.

Conclusion: Increase in binding energy and the number of H-bonds established by AQCMs with below 3.40 Å distance interactions allows a valuable starting point in order to optimize compounds for further investigation. Pharmacokinetics and toxicological profile build up the applicability of quinoline-3-carboxamide moiety as a potential new candidate for the cure of cancer that could help the medicinal chemists for additional extensive in vitro, in vivo chemical, and pharmacological investigations.

Keywords: Molecular docking, PDGFRα, pharmacokinetics, H-bond, structure-based drug design, binding affinity.

« Previous Next »
Graphical Abstract

[1]
Rashid HU, Xu Y, Muhammad Y, Wang L, Jiang J. Research advances on anticancer activities of matrine and its derivatives: An updated overview. Eur J Med Chem 2019; 161: 205-38.
[http://dx.doi.org/10.1016/j.ejmech.2018.10.037] [PMID: 30359819]
[2]
Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis 2017; 9(3): 448-51.
[http://dx.doi.org/10.21037/jtd.2017.02.75] [PMID: 28449441]
[3]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[4]
Murad H, Hawat M, Ekhtiar A, et al. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast can-cer cells by sulfated polysaccharide extracted from Laurencia papillosa. Cancer Cell Int 2016; 16(1): 39.
[http://dx.doi.org/10.1186/s12935-016-0315-4] [PMID: 27231438]
[5]
Sun C, Bernards R. Feedback and redundancy in receptor tyrosine kinase signaling: Relevance to cancer therapies. Trends Biochem Sci 2014; 39(10): 465-74.
[http://dx.doi.org/10.1016/j.tibs.2014.08.010] [PMID: 25239057]
[6]
Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev 2016; 28: 53-61.
[http://dx.doi.org/10.1016/j.cytogfr.2015.10.002] [PMID: 26547628]
[7]
Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009; 9(1): 28-39.
[http://dx.doi.org/10.1038/nrc2559] [PMID: 19104514]
[8]
Abdullahi M, Shallangwa GA, Uzairu A. In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype. Beni Suef Univ J Basic Appl Sci 2020; 9(2): 1-12.
[9]
Mustapha A, Shallangwa G, Ibrahim MT, et al. QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against Leukemia cell line (K562). J Turk Chem Soc Sect A 2018; 5(3): 1387-98.
[http://dx.doi.org/10.18596/jotcsa.457618]
[10]
Isyaku Y, Uzairu A, Uba S. Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents. Heliyon 2020; 6(4): e03724.
[http://dx.doi.org/10.1016/j.heliyon.2020.e03724] [PMID: 32322718]
[11]
Dervisis N, Klahn S. Therapeutic innovations: Tyrosine kinase inhibitors in cancer. Vet Sci 2016; 3(1): 4.
[http://dx.doi.org/10.3390/vetsci3010004] [PMID: 29056714]
[12]
Longo DL. Imatinib changed everything. N Engl J Med 2017; 376(10): 982-3.
[http://dx.doi.org/10.1056/NEJMe1700833] [PMID: 28273011]
[13]
Attique SA, Hassan M, Usman M, et al. A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. Int J Environ Res Public Health 2019; 16(6): 923.
[http://dx.doi.org/10.3390/ijerph16060923] [PMID: 30875817]
[14]
Chaudhari P, Bari S. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: Pharmacophore modeling, 3D QSAR, docking studies, and virtual screening. Mol Divers 2016; 20(1): 41-53.
[http://dx.doi.org/10.1007/s11030-015-9635-x] [PMID: 26416560]
[15]
Govender H, Mocktar C, Koorbanally NA. Synthesis and bioactivity of quinoline-3-carboxamide derivatives. J Heterocycl Chem 2018; 55(4): 1002-9.
[http://dx.doi.org/10.1002/jhet.3132]
[16]
Patel R, Chudasama R, Solanki R, Patel P, Parmar K, Munshi NS. Structure prediction and molecular docking studies of aromatic hydro-carbon sensing proteins TbuT, HbpR and PhnR to detect priority pollutants. J Environ Sci Health Part A Tox Hazard Subst Environ Eng 2020; 55(2): 126-41.
[http://dx.doi.org/10.1080/10934529.2019.1672457] [PMID: 31566066]
[17]
Hasan M, Hasan R, Hazrat AM, Rabbee MF, Rejwan HM, Joy ZF. In-silico characterization and homology modeling of catechol 1,2 dioxy-genase involved in processing of catechol-an intermediate of aromatic compound degradation pathway. Glob J Sci Front Res 2015; 1: 1-13.
[18]
Gasteiger E, Hoogland C, Gattiker A, et al. Protein Identification and Analysis Tools on the ExPASy Server The Proteomics Protocols Handbook. Totowa, N. J: Humana Press 2005; pp. 571-608.
[19]
Bhattacharya D, Nowotny J, Cao R, Cheng J. 3Drefine: An interactive web server for efficient protein structure refinement. Nucleic Acids Res 2016; 44(W1): W406-9.
[http://dx.doi.org/10.1093/nar/gkw336] [PMID: 27131371]
[20]
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. AQUA and PROCHECK-NMR: Programs for checking the quali-ty of protein structures solved by NMR. J Biomol NMR 1996; 8(4): 477-86.
[http://dx.doi.org/10.1007/BF00228148] [PMID: 9008363]
[21]
Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci 1993; 2(9): 1511-9.
[http://dx.doi.org/10.1002/pro.5560020916] [PMID: 8401235]
[22]
Singh SP, Konwar BK. Molecular docking studies of quercetin and its analogues against human inducible nitric oxide synthase. Springerplus 2012; 1(1): 69.
[http://dx.doi.org/10.1186/2193-1801-1-69] [PMID: 23556141]
[23]
Umar AB, Uzairu A, Shallangwa GA, Uba S. Design of potential anti-melanoma agents against SK-MEL-5 cell line using QSAR modeling and molecular docking methods. SN Appl Sci 2020; 2(5): 1-8.
[http://dx.doi.org/10.1007/s42452-020-2620-8]
[24]
Adeniji SE, Arthur DE, Abdullahi M, Haruna A. Quantitative structure–activity relationship model, molecular docking simulation and computational design of some novel compounds against DNA gyrase receptor. Chem Afr 2020; 3(2): 391-408.
[http://dx.doi.org/10.1007/s42250-020-00132-9]
[25]
Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friend-liness of small molecules. Sci Rep 2017; 7(1): 42717.
[http://dx.doi.org/10.1038/srep42717] [PMID: 28256516]
[26]
Daina A, Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016; 11(11): 1117-21.
[http://dx.doi.org/10.1002/cmdc.201600182] [PMID: 27218427]

Rights & Permissions Print Cite
Article Metrics
16
1
© 2024 Bentham Science Publishers | Privacy Policy